ART Adherence, Resistance, and Long-term HIV Viral Suppression in Postpartum Women.
Andrew D ReddElton MukondaNai-Chung HuTamsin K PhilipsAllison ZerbeMaia LesoskyNei-Yuan HsiaoWilliam ClarkeSteven J ReynoldsElaine J AbramsLandon MyerPublished in: Open forum infectious diseases (2020)
HIV+ South African women who achieved viral suppression during routine antenatal care, but later experienced a viremic episode (viral load >1000 copies/mL), were examined for presence of antiretrovirals and classified as "nonadherers" or "suboptimal adherers." Women were tested for drug resistance mutations (DRMs) at several time points and underwent viral load testing 36-60 months postpartum. Suboptimal adherers were more likely to have DRM detected during their viremic episode (P = .03) and at a subsequent viremic time point (P = .05). There was no difference in levels of viral suppression 36-60 months later in women with DRM detected vs women who had no evidence of DRM (P = .5).
Keyphrases
- polycystic ovary syndrome
- antiretroviral therapy
- hiv infected
- pregnancy outcomes
- sars cov
- hepatitis c virus
- hiv positive
- human immunodeficiency virus
- cervical cancer screening
- healthcare
- pregnant women
- breast cancer risk
- type diabetes
- adipose tissue
- metabolic syndrome
- pain management
- weight loss
- preterm birth
- glycemic control
- men who have sex with men